至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Identification of Human Single-Domain Antibodies Against SARS-CoV-2

Cell Host Microbe. 2020-06; 
Yanling Wu , Cheng Li , Shuai Xia , Xiaolong Tian , Yu Kong , Zhi Wang , Chenjian Gu , Rong Zhang , Chao Tu , Youhua Xie , Zhenlin Yang , Lu Lu , Shibo Jiang , Tianlei Ying
Products/Services Used Details Operation
Gene Synthesis The allele genes joined with the identical CDR3 and FR4 (ARLRDGFNNGFDYWGQGTLVTVSS), as well as a previously reported camelid-derived nanobody that targets human TNF-α (12), were synthesized (Genscript, Nanjing, China), and then subcloned into the pComb3x vector with N-terminal OmpA signal peptide (MKKTAIAIAVALAGFATVAQA) and C-terminal tags comprising a hexahistidine (His6) tag and a Flag tag in tandem. Get A Quote

摘要

The worldwide spread of COVID-19 highlights the need for an efficient approach to rapidly develop therapeutics and prophylactics against SARS-CoV-2. The SARS-CoV-2 spike protein, containing the receptor-binding domain (RBD) and S1 subunit involved in receptor engagement, is a potential therapeutic target. We describe the development of a phage-displayed single-domain antibody library by grafting naive complementarity-determining regions (CDRs) into framework regions of a human germline immunoglobulin heavy chain variable region (IGHV) allele. Panning this library against SARS-CoV-2 RBD and S1 subunit identified fully human single-domain antibodies targeting five distinct epitopes on SARS-CoV-2 RBD with subnanom... More

关键词

CR3022; RBD; SARS-CoV-2; nanobody; single-domain antibody; trimeric interface.